Expert Analysis

• Protecting AI-Driven Innovation In Life Sciences IP

  

  Recent developments, including the U.S. Patent and Trademark Office's evolving inventorship standards, and the impact of artificial intelligence on the "person of ordinary skill in the art" standard demand that life sciences companies elevate AI patent strategy to a top priority, says Sandra Haberny at Quinn Emanuel.

• NY's UCC Updates Spell Change In Digital Asset Lending

  

  Given the state’s role as a preferred jurisdiction for financing transactions, New York’s recent enactment of Uniform Commercial Code amendments, which establish control as a central concept for determining who has rights to a digital asset, will encourage nationwide growth toward a more technology-neutral approach to secured transactions, say attorneys at Manatt.

• How Trump's Nuclear EO Has Transformed The NRC

  

  In the year since President Donald Trump issued Executive Order No. 14300, directing sweeping reforms of the U.S. Nuclear Regulatory Commission, the agency has revised key oversight programs and proposed major rulemakings and new licensing frameworks — but the NRC must continue to center transparency and trust as key values, says Brooke Clark at Morgan Lewis.

• Opinion

  Agentic AI And Securities Law: Steps Congress Should Take

  

  Agentic artificial intelligence technology doesn't fit comfortably into the existing securities regulatory landscape, so Congress should avoid repeating the mistakes that led to the legal uncertainty crypto companies and investors have faced over the past decade-plus by providing a legislative framework before AI fully matures, says Joseph A. Hall at Davis Polk.

• Weighing Trade-Offs Of SEC's Semiannual Reporting Proposal

  

  Though public companies could benefit from a recent U.S. Securities and Exchange Commission proposal that would allow them to file earnings reports just twice a year, widespread adoption could also increase market volatility, complicate capital raising and fragment disclosure standards to the detriment of issuers and investors, say attorneys at Seward & Kissel.

• High Court's Hikma Decision Reshapes 'Skinny Label' Suits

  

  The U.S. Supreme Court's decision in Hikma v. Amarin marks a significant victory for generic drug manufacturers, but rather than putting an end to so-called skinny label inducement claims, it narrows and refocuses them, say attorneys at Sterne Kessler.

• Virginia's Cannabis Retail Veto Leaves Industry In Legal Limbo

  

  Virginia Gov. Abigail Spanberger's recent veto of legislation that would have established a regulated retail cannabis framework halts momentum built by the General Assembly, but it also sends important signals about what a future regulatory framework must address to survive, says Charles Slemp at Cozen.

• Opinion

  At High Court, Oil Cos.' Suncor Preemption Claims Fall Short

  

  In Suncor Energy v. Boulder County, pending before the U.S. Supreme Court, oil and gas companies argue that municipalities' climate deception claims are equivalent to emissions standards for their industry — but the suit is ultimately incapable of imposing such standards, say Thomas McGarity at the University of Texas School of Law and James Goodwin at the Center for Progressive Reform.

• What Colorado AI Law's Major Rewrite Means For Employers

  

  Colorado's landmark law regulating employers' use of artificial intelligence tools was recently replaced with a narrower regime that eliminates many burdensome obligations, but still imposes a host of requirements focused on transparency and accountability, say attorneys at Proskauer.

• Operational AI Washing: The Next Frontier Of Fiduciary Risk

  

  While there are still no final Delaware decisions applying Caremark specifically to artificial intelligence governance failures, previous case law provides a blueprint, so the question for boards is whether their governance architectures will satisfy Caremark when the first cases are decided, say attorneys at Akerman.

• A Look At The Court's Next Steps In Live Nation Antitrust Case

  

  Following a recent jury verdict that Live Nation and Ticketmaster operated as a monopoly to fix ticket prices, a New York federal court stands to weigh Live Nation's bid for a new trial, approve the U.S. Department of Justice's March settlement with the defendants, and impose remedies that include full structural separation, say attorneys at Crowell.

• How Crypto Firms Can Prep As Clarity Act Inches Toward Law

  

  Though the Digital Asset Market Clarity Act’s road to enactment remains uncertain, the statutory framework for regulating digital commodities recently advanced by the Senate Banking Committee is now sufficiently developed that market participants can begin preparing in several areas where the complicated legislation would affect them, say attorneys at Cahill Gordon.

• Checking For AI Errors Is Now A Two-Way Street

  

  A handful of recent federal and state cases demonstrate the importance of checking for errors generated by artificial intelligence not only in your own court submissions, but also your opponent's, as well as when catching opposing counsel's AI mistakes could result in an award for attorney fees, says Tamara Barago at Hollingsworth.

• Opinion

  SEC Enforcement Reforms Must Address Post-Wells Limbo

  

  The U.S. Securities and Exchange Commission's recent changes to how it notifies companies of a potential enforcement action fail to address what happens after the Wells process is over, highlighting the need for meaningful process reform that includes a formal closure determination, says Kimble Cannon at Mahdavi Bacon.

• Green Card Memo Warps Long-Standing Adjustment Process

  

  A recent policy memorandum that treats a nonimmigrant visa holder’s decision to seek adjustment of status in the U.S., rather than at a U.S. consulate, as an adverse factor reinterprets existing discretionary frameworks, compounds risks for applicants required to apply abroad and changes practitioner approaches to application preparation, says attorney Jack Jrada.